EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects

Yingliang Dai iD, Ben J Harrison iD, Christopher G Davey iD, Trevor Steward iD

International Journal of Neuropsychopharmacology · 04.02.2025 · 28 (2)

DOI: 10.1093/ijnp/pyaf010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 08.02.2025. Verfasst von Yingliang Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Ketamine, Antidepressive Agents, Brain, Cognition. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Future Fund, Brain & Behavior Research Fund, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine is an N-methyl-D-aspartate receptor antagonist that has shown effectiveness as a rapidly acting treatment for depression. Although advances have been made in understanding ketamine’s antidepressant pharmacological and molecular mechanisms of action, the large-scale neurocognitive mechanisms driving its therapeutic effects are less clearly understood. To help provide such a framework, we provide a synthesis of current evidence linking ketamine treatment to the modulation of brain systems supporting reward processing, interoception, and self-related cognition. We suggest that ketamine’s antidepressant effects are, at least in part, driven by dynamic multi-level influences across these key functional domains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAntidepressive AgentsBrainCognitionExcitatory Amino Acid AntagonistsHumansAnimalsRewardReceptors, N-Methyl-D-Aspartate

Stichwörter der Autor:innen

antidepressantdepressionketamineneurobiologyneurocognitive

Substanzen

KetamineAntidepressive AgentsExcitatory Amino Acid AntagonistsReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
  • Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Yingliang Dai, Ben J Harrison, Christopher G Davey, Trevor Steward

Förderung

  • Medical Research Future Fund
  • Brain & Behavior Research Fund
  • China Scholarship Council
  • National Health and Medical Research Council
  • NHMRC Career Development Fellowship

Zitieren

APA

Dai, Y., Harrison, B. J., Davey, C. G., & Steward, T. (2025). Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects. International Journal of Neuropsychopharmacology, 28(2). https://doi.org/10.1093/ijnp/pyaf010

Vancouver

Dai Y, Harrison BJ, Davey CG, Steward T. Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects. International Journal of Neuropsychopharmacology. 2025;28(2). doi:10.1093/ijnp/pyaf010

BibTeX
@article{Dai2025,
  author = {Dai, Yingliang and Harrison, Ben J and Davey, Christopher G and Steward, Trevor},
  title = {Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  volume = {28},
  number = {2},
  doi = {10.1093/ijnp/pyaf010}
}
Kostenlos starten →